Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT00288119 is an observational study sponsored by Case Western Reserve University. As of 21 Nov 2026, it is recruiting participants. It studies Barrett's Esophagus and Esophageal Neoplasm. The registry lists an enrollment of 2,000 participants at 10 sites in 1 country. The registry lists a start date of 1 Oct 2005 and a primary completion date of 31 Jul 2028. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00288119 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | Case Western Reserve University |
| Enrollment | 2,000 |
| Registered sites | 10 |
| Countries | 1 |
| Conditions | Barrett's Esophagus and Esophageal Neoplasm |
| Start | 1 Oct 2005 |
| Primary completion | 31 Jul 2028 |
| Study completion | 31 Jul 2028 |
| Last update posted | 10 Aug 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Amitabh Chak, MD
University Hospitals Cleveland Medical Center, CWRU, Cleveland, OH
Principal InvestigatorKOL profile → - Andrew Kaz, MD
VA Puget Sound Health Care System
Principal Investigator - Ganapathy Prasad, M.D.
Mayo Clinic
Principal Investigator - Gary W Falk, MD, MS
University of Pennsylvania
Principal Investigator - Jean Wang, MD
Washington University School of Medicine
Principal Investigator - John Dumont, D.O.
University Hospitals Cleveland Medical Center
Principal Investigator - Julian Abrams, MD
Columbia University
Principal Investigator - Marcia Canto, M.D.
Johns Hopkins University
Principal Investigator - Nicholas J Shaheen, M.D.
University of North Carolina, Chapel Hill
Principal Investigator - Prashanthi Thota, M.D.
The Cleveland Clinic
Principal Investigator - William Grady, MD
Fred Hutchinson Cancer Research Center, UWMC, Seattle, WA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Johns Hopkins Hospital
Baltimore
Marcia I Canto, M.D.Recruiting
- Mayo Clinic
Rochester
Ganapathy A Prasad, M.D.Recruiting
- Washington University School of Medicine
St Louis
Jean Wang, MDRecruiting
- Columbia University Medical Center
New York
Julian Abrams, MDRecruiting
- University of North Carolina at Chapel Hill
Chapel Hill
Nicholas J Shaheen, M.D.Recruiting
- Cleveland Clinic
Cleveland
Prashanthi Thota, MDRecruiting - Recruiting
- University of Pennsylvania
Philadelphia
Gary W. Falk, MD, MSRecruiting
- Fred Hutchinson Cancer Research Center, Uwmc
Seattle
Kaz Andrew, MDWilliam Grady, MDRecruiting - Va Puget Sound Health Care System
Seattle
Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00288119
Each answer restates registry values shown on this page.
What is NCT00288119?
NCT00288119 is an observational study sponsored by Case Western Reserve University. It studies Barrett's Esophagus and Esophageal Neoplasm.
Is NCT00288119 recruiting?
As of 21 Nov 2026, it is recruiting participants. 10 of its 10 sites list their own status as recruiting.
Who leads NCT00288119?
The registry names Amitabh Chak, MD (principal investigator, University Hospitals Cleveland Medical Center, CWRU, Cleveland, OH), Andrew Kaz, MD (principal investigator, VA Puget Sound Health Care System), Ganapathy Prasad, M.D. (principal investigator, Mayo Clinic) and 8 more officials as overall officials.
Where does NCT00288119 run?
The registry lists 10 sites in 1 country. Every site with a stated country is in one country: United States.
When is NCT00288119 expected to complete?
The registry lists a primary completion date of 31 Jul 2028 and a study completion date of 31 Jul 2028. The sponsor last updated the record on 10 Aug 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.